본문 바로가기

Quercitrin, the Main Compound in Wikstroemia indica, Mitigates Skin Lesions in a Mouse Model of 2,4-Dinitrochlorobenzene-Induced Contact Hypersensitivity

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q3Scopus Q2
피인용
Web of Science 16Scopus 18
FWCI (Scopus)
0
JCR IF
JCR 2019 1.813
ISSN
1741-427X

저자

  1. 제갈종환제1저자College of Pharmacy, Pusan National University, Busan 46241 Republic of Korea pusan.ac.kr
  2. Park, No-JuneNatural Products Research Institute, Korea Institute of Science and Technology, Gangneung 25451 Republic of Korea kist.re.kr
  3. 이소연College of Pharmacy, Pusan National University, Busan 46241 Republic of Korea pusan.ac.kr
  4. 조범근College of Pharmacy, Pusan National University, Busan 46241 Republic of Korea pusan.ac.kr
  5. Bong, Sim-KyuNatural Products Research Institute, Korea Institute of Science and Technology, Gangneung 25451 Republic of Korea kist.re.kr
  6. Kim, Su-Nam교신저자Natural Products Research Institute, Korea Institute of Science and Technology, Gangneung 25451 Republic of Korea kist.re.kr
  7. 양민혜교신저자College of Pharmacy, Pusan National University, Busan 46241 Republic of Korea pusan.ac.kr

초록

Hapten-induced contact hypersensitivity (CHS) is widely utilized to induce immune activation in animal models of allergic contact dermatitis. Our previous findings suggested that the 95% EtOH extract ofWikstroemia indica(L.) C. A. Mey. has antiallergic and anti-inflammatory effects in DNCB-treated CHS SKH-1 hairless mice. The aim of this study was to evaluate the protective effects of compounds isolated from the EtOAc fraction ofW. indicain RBL-2H3 cells and 2,4-dinitrochlorobenzene- (DNCB-) induced CHS mice. Of eight compounds inW. indica, that is, umbelliferone, daphnoretin, wikstrocoumarin, (+)-syringaresinol, tricin, (+)-lariciresinol,erythro-guaiacylglycerol-beta-coniferyl ether, and quercitrin, quercitrin exhibited the most antiallergic activity against antigen-induced beta-hexosaminidase release and IL-4 mRNA expression, which are markers of degranulation in RBL-2H3 cells. After a 7-sensitizing period, 14 days of DNCB treatment with or without topical pimecrolimus (1%) or quercitrin (0.5%) treatment, quercitrin was found to suppress DNCB-induced increases in serum IL-4 and IgE concentrations and transepidermal water loss. These results indicate that quercitrin has therapeutic potential for treatment of allergies and allergy-related contact dermatitis.

키워드

ATOPIC-DERMATITISMOLECULAR-MECHANISMSBARRIER DYSFUNCTIONDIETARY FLAVONOIDSIMMUNE-RESPONSESQUERCETIN

식별자

Scopus EID
2-s2.0-85089144968
WoS UID
000553395700005